gruns glp-1 Advanced Intra-Oral Spray, by Results RNA, 4 oz and Iron Grüns Superfood Gummies offer GLP-1

Ethics declarations Conflict of interest Julia Herrou, Guillaume Mabilleau, Jean-Michel Lecerf, Thierry Thomas, Emmanuel Biver and Julien Paccou declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Sukumar J., Raghavendra A., Pasyar S., et al., Retrospective Study of GLP1 Receptor Agonists in Breast Cancer Survivors: Weight Loss and Patient Outcomes, Presented at the San Antonio Breast Cancer Symposium (SABCS), December 1013, 2024

There is a lack of data evaluating the types of reactions associated with this medication class, and this study aimed to characterize the types of cutaneous reactions seen across different GLP-1 agonists, and whether differences exist in reactions based on the reason for medication use

Nonetheless, our case series also has notable strengths

The FDAs action also opened a door for Medicare coverage in patients with cardiovascular disease an early sign that access for these expensive medicines could expand beyond the well-insured

Bahnson JL, Knowler WC, Bantle JP, Bertoni AG, Bray GA, Chen H et al (2014) Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial